Ben Shai is a highly educated individual with extensive experience in the field of virology and cell biology. He holds a Ph.D. in Virology and Cell Biology from Tel Aviv University, where he also earned a Master's degree in the same field, and a Bachelor's degree in Biotechnology. Ben has over a decade of experience working in various capacities within the science community. He has worked as a lecturer, teacher assistant, researcher, scientific consultant, and board member for several organizations.

Ben currently works as an analyst at Pontifax Venture Capital, where he applies his expertise in various aspects of the biotech industry. Ben's experience in virology and cell biology makes him a valuable asset to the investment team. Additionally, he has previously held positions on the board of several biotech companies, including Pantheon Biosciences, ExploreBio, Immunorizon, and RelTar Therapeutics.

Before joining Pontifax Venture Capital, Ben worked as a senior researcher and R&D scientist at XoNovo Ltd. He also worked as a lecturer at Tel Aviv University and The Open University of Israel. Ben has published several research papers and has shared his knowledge with others by being a medical instructor and first aid instructor.

Overall, Ben Shai's background in virology, cell biology, and biotechnology make him a valuable asset to any organization working in these fields. His expertise and experience are well suited to scientific consulting, research, and investment analysis.